As CD133 is a marker present in a subset of cancer stem-like cells in patients with laryngeal carcinoma,26 we measured CD133 expression in DSCs and Hep2 cells by flow-assisted cell sorting analysis. This evidence concerns the gene PROM1 and cancer.